Single Tablet Combination Therapy Patient Experience Simulation

GETTING STARTED

When sharing this patient experience simulation on screen, sharing sound must be enabled for all group members to listen to the audio portions.

Test your sound by clicking the play button below.

GROUP TASKS

Briefly introduce yourselves to each other, then select one person to continue reading this page aloud.

Over the course of this simulation, we will be taking in a lot of information and sharing our reflections on what we’ve learned. We should all try to pay attention to how the simulated patient experience compares to our own understanding of the PAH patient journey.

We will have approximately 65 minutes to complete this simulation. Our group may feel a sense of time compression, but we should do our best with the information we have to stay on track.

Information and data gathering is key in this simulation experience. It will be important for our team to pay close attention to the details we discover as we:

  • Listen to audio conversations
  • Explore infomation
  • Read stakeholders’ perspectives
  • Complete activities and reflections

There are a few different tasks that members of our group will perform during the stakeholder experience simulation. Read the following role descriptions and take note of who on your team will perform each role.

Navigator: Guides the group through the simulation website and captures responses to questions and activities.

Important: Remember to hit each “submit” button to save your answers.

Timekeeper: Notes the recommended time for each section and helps the team stay within time limits.

Readers: Reads aloud all instructions and all written content to the rest of the team.

LET'S GET STARTED

DISCLAIMERS

Johnson & Johnson Innovative Medicine (JJIM) has an NDA for an investigational Single Tablet Combination Therapy (STCT) whose efficacy and safety has not been established and is currently under review at the FDA. This simulation is a hypothetical forward looking scenario of an STCT being available for the treatment of Pulmonary Arterial Hypertension (PAH).

This simulation is intended for home office team members – everyone supporting strategy and planning for macitentan/tadalafil STCT, MSLs, and HCPs involved in advisory boards for feedback in the area of PAH.

This simulation is for internal use only. It should not be used for promotional purposes, and is not for external use or distribution.

The stakeholders in this simulation are fictional.